Rekombinanter TNFSF4 (Oxelumab Biosimilar) Antikörper
Reaktivität: Human
FACS, BR
Wirt: Human
Monoclonal
R4930
unconjugated
Recombinant Antibody
-
- Target Alle TNFSF4 (Oxelumab Biosimilar) Produkte
- TNFSF4 (Oxelumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Human
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser TNFSF4 (Oxelumab Biosimilar) Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), Blocking Reagent (BR)
- Spezifität
- Binds to human OX40L.
- Produktmerkmale
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Aufreinigung
- Purified antibody.
- Reinheit
- > 98 % as determined by SDS-PAGE
- Endotoxin-Niveau
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Immunogen
- Oxelumab binds to human OX40L, the ligand of OX40, stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells.
- Klon
- R4930
- Isotyp
- IgG1 kappa
-
-
- Applikationshinweise
- This antibody binds to the co-stimulatory OX40L, inhibiting its interaction with OX40.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- TNFSF4 (Oxelumab Biosimilar)
- Abstract
- TNFSF4 (Oxelumab Biosimilar) Produkte
- Synonyme
- CD134L antikoerper, CD252 antikoerper, GP34 antikoerper, OX-40L antikoerper, OX4OL antikoerper, TXGP1 antikoerper, TNF superfamily member 4 antikoerper, TNFSF4 antikoerper
- Substanzklasse
- Biosimilar
- Hintergrund
- CD252, TNFSF4, tumor necrosis factor (TNF) superfamily member 4, OX40 ligand, OX-40L, TAX transcriptionally-activated glycoprotein 1, TXGP1, gp34
- UniProt
- P23510
-
Sie sind hier:
